AlphaStocks
5.2
Consider Buy

Viatris Inc (VTRS)

Health Care / Pharmaceuticals

S&P 500

$15.37

Below average on several measures. Research carefully.

Consider Buy

Score based on 2 of 5 models — limited data

#494out of 1123 in Health Care

Is Viatris Inc a Good Investment in 2026?

Viatris Inc (VTRS) scores 5.2 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Lynch model rates Viatris Inc as Attractive. However, the Buffett model rates it Caution. Viatris Inc currently trades below its estimated fair value of $18, suggesting potential upside. Viatris Inc ranks #494 out of 1123 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE114.4Market Cap18B

Estimated Fair Value

$17.6313% below

Trading near or slightly below estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

3/9

Buffett

Caution

Business quality & competitive moat

Graham

Limited Data

Price vs intrinsic value

Lynch

Attractive

Growth rate vs price (PEG)

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is Viatris Inc (VTRS) a good investment?
Based on AlphaStocks' composite analysis, Viatris Inc (VTRS) scores 5.2 out of 10, earning a Consider Buy rating. This score is below average, suggesting caution. Trading near or slightly below estimated fair value.
What is Viatris Inc's Piotroski F-Score?
Viatris Inc's Piotroski F-Score status is Neutral. The raw score is 3/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is VTRS overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $18, VTRS appears undervalued. The stock currently trades 13% below its estimated fair value. Trading near or slightly below estimated fair value.
How does VTRS compare to other Health Care stocks?
Viatris Inc ranks #494 out of 1123 stocks in the Health Care sector, placing it in the top 44% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about VTRS?
AlphaStocks evaluates VTRS using five proven investment models. Piotroski: Neutral; Buffett: Caution; Lynch: Attractive. These models are combined into a single composite score of 5.2/10.

Similar Stocks

BFAMPARRAZN

Compare VTRS with

VTRS vs BFAMVTRS vs PARRVTRS vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer